De-zhen Guo

Shanghai Key Laboratory Of Organ Transplantation
Zhongshan, 200032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Correction: Single-cell tumor heterogeneity landscape of hepatocellular carcinoma: unraveling the pro-metastatic subtype and its interaction loop with fibroblasts.

Correction: Single-cell tumor heterogeneity landscape of hepatocellular carcinoma: unraveling the pro-metastatic subtype and its interaction loop with fibroblasts.

Journal: Molecular cancer

Published: March 18, 2026

Application of targeted deep sequencing for management of hepatocellular carcinoma in a real-world setting: prediction of MRD and adjuvant lenvatinib response.

Application of targeted deep sequencing for management of hepatocellular carcinoma in a real-world setting: prediction of MRD and adjuvant lenvatinib response.

Journal: Cancer letters

Published: July 16, 2025

GUIDE: a prospective cohort study for blood-based early detection of gastrointestinal cancers using targeted DNA methylation and fragmentomics sequencing.

GUIDE: a prospective cohort study for blood-based early detection of gastrointestinal cancers using targeted DNA methylation and fragmentomics sequencing.

Journal: Molecular cancer

Published: April 07, 2025

Postoperative circulating tumor cells predict the benefits of tyrosine kinase inhibitor for hepatocellular carcinoma after transplantation.

Postoperative circulating tumor cells predict the benefits of tyrosine kinase inhibitor for hepatocellular carcinoma after transplantation.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: August 28, 2024

Single-cell tumor heterogeneity landscape of hepatocellular carcinoma: unraveling the pro-metastatic subtype and its interaction loop with fibroblasts.

Single-cell tumor heterogeneity landscape of hepatocellular carcinoma: unraveling the pro-metastatic subtype and its interaction loop with fibroblasts.

Journal: Molecular cancer

Published: February 01, 2024

Early detection and prognosis evaluation for hepatocellular carcinoma by circulating tumour DNA methylation: A multicentre cohort study.

Early detection and prognosis evaluation for hepatocellular carcinoma by circulating tumour DNA methylation: A multicentre cohort study.

Journal: Clinical and translational medicine

Published: January 27, 2024

Serial circulating tumor DNA profiling predicts tumor recurrence after liver transplantation for liver cancer.

Serial circulating tumor DNA profiling predicts tumor recurrence after liver transplantation for liver cancer.

Journal: Hepatology international

Published: April 26, 2023

Prognosis of spontaneously ruptured hepatocellular carcinoma: a propensity score matching study.

Prognosis of spontaneously ruptured hepatocellular carcinoma: a propensity score matching study.

Journal: Journal of cancer research and clinical oncology

Published: April 02, 2023

Prognostic model for predicting outcome and guiding treatment decision for unresectable hepatocellular carcinoma treated with lenvatinib monotherapy or lenvatinib plus immunotherapy.

Prognostic model for predicting outcome and guiding treatment decision for unresectable hepatocellular carcinoma treated with lenvatinib monotherapy or lenvatinib plus immunotherapy.

Journal: Frontiers in immunology

Published: January 10, 2023

Circulating immune index predicting the prognosis of patients with hepatocellular carcinoma treated with lenvatinib and immunotherapy.

Circulating immune index predicting the prognosis of patients with hepatocellular carcinoma treated with lenvatinib and immunotherapy.

Journal: Frontiers in oncology

Published: November 28, 2022

A bibliometric analysis of primary ovarian insufficiency from 2010 to 2020.

A bibliometric analysis of primary ovarian insufficiency from 2010 to 2020.

Journal: Climacteric : the journal of the International Menopause Society

Published: April 04, 2022

Efficacy and safety of lenvatinib for preventing tumor recurrence after liver transplantation in hepatocellular carcinoma beyond the Milan criteria.

Efficacy and safety of lenvatinib for preventing tumor recurrence after liver transplantation in hepatocellular carcinoma beyond the Milan criteria.

Journal: Annals of translational medicine

Published: March 14, 2022

Showing 1-12 of 18

Last Updated: 09/26/2026